Ara
Toplam kayıt 9, listelenen: 1-9
Can Activation Induced Cytidine Deaminase Lead to Genetic Instability in Bcr-Abl Negative Myeloproliferative Neoplasms?
(AMER SOC HEMATOLOGY, 2012)
…
Eculizumab therapy for aHUS associated with heterozygous factor I mutation
(SPRINGER, 2012)
…
Eculizumab therapy in a child with hemolytic uremic syndrome and CFI mutation
(SPRINGER, 2012)
Background Hemolytic uremic syndrome (HUS) is the most common cause of acute renal failure in childhood. It usually occurs after a prodromal episode of diarrhea and it leads to significant morbidity and mortality during ...
Glycoprotein Ib-alpha Kozak polymorphism in ischemic stroke
(MANEY PUBLISHING, 2012)
Background: Recently, a T/C polymorphism in the Kozak sequence of glycoprotein Ib-alpha (GPIb-alpha) gene at position 25 from the initiator ATG codons, has been identified. The presence of -5C allele increases the surface ...
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
(SPRINGER, 2012)
Polycythemia vera (PV), essential thrombocythemia (ET) and idiopathic myelofibrosis (IMF), collectively known as Philadelphia-negative (Ph-negative) chronic myeloproliferative neoplasms (MPNs), MPNs represent the most ...
The impact of platelet membrane glycoprotein Ib alpha and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome
(PERGAMON-ELSEVIER SCIENCE LTD, 2012)
Background: Pathogenesis of thrombus formation in antiphospholipid syndrome (APS) is not clear. Platelet membrane glycoprotein (GP) receptors play important roles in development of thrombosis. Objectives: We investigated ...
Overexpression of Fc mu receptor (FCMR, TOSO) gene in chronic lymphocytic leukemia patients
(HUMANA PRESS INC, 2012)
Rai and Binet staging systems that have been used as a standard method for evaluating the prognosis of chronic lymphocytic leukemia (CLL) have some restrictions in distinguishing the early stage CLL patients that will ...